Maria I Fiel, MD

Clinical Focus

• Adenomas
• Amyloidosis
• Autoimmune Hepatitis
• Bile Duct Diseases
• Biopsy
• Cholangiocarcinoma
• Cirrhosis
• Colon Polyps
• Colorectal Cancer

Show More

• Adenomas
• Amyloidosis
• Autoimmune Hepatitis
• Bile Duct Diseases
• Biopsy
• Cholangiocarcinoma
• Cirrhosis
• Colon Polyps
• Colorectal Cancer
• Esophageal Cancer
• Fatty Liver Disease
• Hemangioma
• Hepatitis B
• Hepatitis C
• Hepatocellular Carcinoma
• IBD
• Liver Cancer
• Liver Transplant
• Peptic Ulcer
• Small Bowel Resection
• Ulcerative Colitis

Research

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:54

Article:226

Review Article:17

Comment/Debate:7

Letter:4

Editorial:2

Chapter:1

Recent Artifacts

• AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury
• Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development
• An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis
• Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
• Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology
• Erratum to “Giant pedunculated hepatocellular adenoma masquerading as a subdiaphragmatic mass: Diagnostic challenges of a rare tumor” [Radiology Case Reports 16 (2021) 84–89, (Radiology Case Reports (2021) 16(84-89) (S1930043320305665), (10.1016/j.radcr.2020.10.047))
• Heterogeneity of hepatic steatosis definitions and reporting of donor liver frozen sections among pathologists: A multicenter survey
• Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis
• Recurrent Liver Allograft Injury in Patients With Donor-Derived Malignancy Treated With Immunosuppression Cessation and Retransplantation
• The Quantification and Significance of Extramedullary Hematopoiesis Seen on Liver Biopsy Specimens

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Fiel during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.